SE428126B - Forfarande att framstella terapeutiskt aktiva 3-pyrrolidinyl-alfa,alfa-difenylacetamider och 3-pyrrolidinyl-alfa,alfa-difenylmetaner - Google Patents

Forfarande att framstella terapeutiskt aktiva 3-pyrrolidinyl-alfa,alfa-difenylacetamider och 3-pyrrolidinyl-alfa,alfa-difenylmetaner

Info

Publication number
SE428126B
SE428126B SE7514375A SE7514375A SE428126B SE 428126 B SE428126 B SE 428126B SE 7514375 A SE7514375 A SE 7514375A SE 7514375 A SE7514375 A SE 7514375A SE 428126 B SE428126 B SE 428126B
Authority
SE
Sweden
Prior art keywords
alfa
pyrrolidinyl
methetanes
difenyl
acetamides
Prior art date
Application number
SE7514375A
Other languages
English (en)
Swedish (sv)
Other versions
SE7514375L (sv
Inventor
Jr W J Welstead
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of SE7514375L publication Critical patent/SE7514375L/xx
Publication of SE428126B publication Critical patent/SE428126B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
SE7514375A 1974-12-26 1975-12-18 Forfarande att framstella terapeutiskt aktiva 3-pyrrolidinyl-alfa,alfa-difenylacetamider och 3-pyrrolidinyl-alfa,alfa-difenylmetaner SE428126B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/536,708 US4002766A (en) 1974-12-26 1974-12-26 Antiarrhythmia methods

Publications (2)

Publication Number Publication Date
SE7514375L SE7514375L (sv) 1976-06-28
SE428126B true SE428126B (sv) 1983-06-06

Family

ID=24139598

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7514375A SE428126B (sv) 1974-12-26 1975-12-18 Forfarande att framstella terapeutiskt aktiva 3-pyrrolidinyl-alfa,alfa-difenylacetamider och 3-pyrrolidinyl-alfa,alfa-difenylmetaner

Country Status (18)

Country Link
US (1) US4002766A (lt)
JP (1) JPS5191255A (lt)
AU (1) AU498763B2 (lt)
BE (1) BE836974A (lt)
CA (1) CA1055396A (lt)
CH (1) CH619932A5 (lt)
DE (1) DE2558501A1 (lt)
DK (1) DK137751B (lt)
ES (1) ES443846A1 (lt)
FI (1) FI753607A (lt)
FR (1) FR2295745A1 (lt)
GB (1) GB1535770A (lt)
IE (1) IE43901B1 (lt)
NL (1) NL185620C (lt)
NO (1) NO754377L (lt)
PH (1) PH13483A (lt)
SE (1) SE428126B (lt)
ZA (1) ZA757974B (lt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133881A (en) * 1977-04-27 1979-01-09 A. H. Robins Company, Incorporated Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods
US4242261A (en) * 1979-07-19 1980-12-30 A. H. Robins Company, Inc. Production of methylene-cycloamines
US4260606A (en) * 1979-07-19 1981-04-07 A. H. Robins Company, Inc. 3-Methyleneazetidine derivatives
US4812452A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino) carbonyl and thiocarbonyl)-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4810703A (en) * 1984-10-19 1989-03-07 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-alpha, alpha-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4594343A (en) * 1984-10-19 1986-06-10 Shanklin Jr James R 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4812451A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-α,.alpha.
IL76583A (en) * 1984-10-19 1988-08-31 Robins Co Inc A H 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them
GB8825505D0 (en) * 1988-11-01 1988-12-07 Pfizer Ltd Therapeutic agents
US5932594A (en) * 1988-11-01 1999-08-03 Pfizer, Inc. Muscarinic receptor antagonists
US5233053A (en) * 1989-03-17 1993-08-03 Pfizer Inc. Pyrrolidine derivatives
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
US6693202B1 (en) * 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
TW200800953A (en) * 2002-10-30 2008-01-01 Theravance Inc Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
JP4767842B2 (ja) * 2003-04-01 2011-09-07 セラヴァンス, インコーポレーテッド β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物
TW200510298A (en) * 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
EP1723142A1 (en) * 2004-03-11 2006-11-22 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
US7071224B2 (en) * 2004-03-11 2006-07-04 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
TW200540154A (en) * 2004-06-10 2005-12-16 Theravance Inc Crystalline form of a substituted pyrrolidine compound
WO2007076158A2 (en) * 2005-12-27 2007-07-05 Teva Pharmaceutical Industries Ltd. Processes for preparing darifenacin hydrobromide
BRPI0807615A8 (pt) * 2007-02-23 2017-12-05 Theravance Inc Compostos de difenilmetil amônico quaternário úteis como antagonistas de receptor muscarínico
EP2146957B1 (en) * 2007-04-24 2013-06-12 Theravance, Inc. Quaternary ammonium compounds useful as muscarinic receptor antagonists
WO2012166909A1 (en) * 2011-06-03 2012-12-06 Galleon Pharmaceuticals, Inc. Compositions and methods for treating breathing control disorders or diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192210A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones
NL6606516A (lt) * 1965-05-17 1966-11-18
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives

Also Published As

Publication number Publication date
DK137751B (da) 1978-05-01
IE43901B1 (en) 1981-07-01
ZA757974B (en) 1976-12-29
PH13483A (en) 1980-05-21
NL7515071A (nl) 1976-06-29
DE2558501C2 (lt) 1987-07-16
NL185620B (nl) 1990-01-02
ES443846A1 (es) 1977-07-16
FI753607A (lt) 1976-06-27
AU8754975A (en) 1977-06-23
NL185620C (nl) 1990-06-01
JPS5191255A (en) 1976-08-10
NO754377L (lt) 1976-06-29
IE43901L (en) 1976-06-26
DE2558501A1 (de) 1976-07-08
BE836974A (fr) 1976-04-16
DK589175A (lt) 1976-06-27
US4002766A (en) 1977-01-11
GB1535770A (en) 1978-12-13
CH619932A5 (lt) 1980-10-31
FR2295745B1 (lt) 1980-06-27
SE7514375L (sv) 1976-06-28
AU498763B2 (en) 1979-03-22
DK137751C (lt) 1978-10-09
JPS612658B2 (lt) 1986-01-27
CA1055396A (en) 1979-05-29
FR2295745A1 (fr) 1976-07-23

Similar Documents

Publication Publication Date Title
SE428126B (sv) Forfarande att framstella terapeutiskt aktiva 3-pyrrolidinyl-alfa,alfa-difenylacetamider och 3-pyrrolidinyl-alfa,alfa-difenylmetaner
AT347588B (de) Arzneimittelwirkstofftraeger
TR18166A (tr) Triazolil-alakanonlar ve triazolil-alkanollar, bunlarin hazirlanisi icin usul ve bunlarin gungisidler olarak kullanilmalari
SE7512612L (sv) Agglomerat, formade strukturer och forfarande for framstellning derav
PL193676A1 (pl) Srodek owadobojczy
SE422440B (sv) Forfarande och anordning for skinnforpackning
BE833044A (fr) 4-arylpiperidines 1, 3, 4 -trisubtituees et leur preparation
IT1042173B (it) Procedimento per preparare butandioli
BE828667A (fr) Preparation active dermatologiquement
TR18260A (tr) Alkiksikarbonilfeniluereler,imal lerine mahsus usul ve harbisidler olarak kullanilmalari
SE7508642L (sv) 7-metoxi-6-tia-tetracykliner och forfarande for framstellning derav
SE7510752L (sv) Galenisk beredning for allopyrinol-langtidsterapi
DK153319C (da) Aktivt carbon og fremgangsmaade til fremstilling deraf
BE829082A (fr) Nouvelles diamines, leur preparation et leur application
SE7512354L (sv) Pyrrolidoner och forfarande for deras framstellning
SE7505736L (sv) Polylaurinlactam, forfarande for framstellning av hogre polylactamer och deras anvendning
IT1047576B (it) Tessuto elastico e procedimento per frabbricarlo
SE7509441L (sv) Athelminitiskt aktiva 2-karbalkoxiamino-bensimidazolyl-5(6)-sulfonsyra-fenylestrar och forfarande for deras framstellning
SE7507238L (sv) Sampolymerisat, och forfarande for deras framstellning och anvendning.
DK306775A (da) Insecticide og miticide thiosulfenylcarbamoyloximer
SE7514344L (sv) 3-fluorobensodiazepiner och forfarande for framstellniing derav
SE417509B (sv) Forfarande for framstellning av anthelmintiskt aktiva 2-karbalkoxiamino-5 (6)-fenyl-sulfonyloxi-bensimidazoler
SE7514113L (sv) 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler och forfarande for deras framstellning
IT1054363B (it) Procedimento per produrre l cisteina e l cistina
BG26352A3 (bg) Инсектицидно средство

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7514375-0

Effective date: 19920704

Format of ref document f/p: F